IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Nephro Care India IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Kolkata and caters to Healthcare - Hospitals And Clinic sector. Corporate Capital Ventures Private is the merchant banker of Nephro Care India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 9th April 2024.
Nephro Care India IPO posted revenues of Rs 26.52 crores and PAT of Rs 4.53 crores in FY24 on annualised basis.Financial results of Nephro Care India IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Nephro Care India IPO PAT Margin is 17.22%, ROCE (Return on Capital Employed) is 36.56% as per latest financial. The below table shows Nephro Care India IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Nephro Care India IPO is Rs 148.38 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Nephro Care India IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Nephro Care India IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Nephro Care India IPO is ₹148.38 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Nephro Care India IPO has a Price-to-Earnings (PE) ratio of 32.73 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Nephro Care India IPO reported revenue of ₹26.52 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Nephro Care India IPO provide insights into sales growth, market demand, and business scalability.
Nephro Care India recorded an EBITDA of ₹ 6.73 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Nephro Care India Profit After Tax (PAT) is ₹4.53 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 26.33 Cr.
EBITDA Margin:
25.57
%
Net Worth: ₹ 13.92 Cr.
Market Capitalisation:
₹ 148.38 Cr.
P/E:
32.73 times
P/BV: 2.69 times
EV/EBITDA: 21.72 times
Nephro Care India operates in Healthcare - Hospitals And Clinic and Hospital In Kolkata. The Issue is listed on NSE EMERGE in Jul, 2024. Nephro Care India IPO size was 41.26 with Issue price of 90.00 .
Merchant Banker(s) of Nephro Care India IPO: Corporate Capital Ventures Private Limited
Nephro Care India IPO subscription was 715.78 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nephro Care India IPO listed at a listing price of 179.55 against the offer price of 90.00.
The current market price of Nephro Care India is 154.75.
Why Us?
